Enumeral Biomedical Holdings announced that it had completed a merger between the company and its subsidiary, Cerulean Group, Inc. Along with the news of the merger, the company also announced the conclusion of its private placement financing, which raised $21.5 million.
Odinah N. Sagun
Breaking News
The California Energy Commission recently endowed a $3 million grant to Pacific Ethanol to develop a product that would act as an alternative for sorghum. Sorghum is being used as a feedstock for ethanol.
Destiny Pharma recently announced in a press release that it was able to raise £2.8 million to fund the clinical trial of a drug aimed to prevent post-surgical infections. The company's recent funding, which was led by British government-backed Angel CoFund, will aid
OneRoofEnergy has made an announcement about funding it has received from an existing shareholder. The company, which is known for its SolarSelect program, acknowledged receipt...
Hallspot, a social network and mobile application aimed at establishing connections between college students and businesses, recently reached a million dollars in its third round of funding, according to the company.
Subscribe to VCpost newsletter
Most Popular
- Neuralink Co-Founder Implies He Left Elon Musk's Brain Implant Company Over Safety Concerns
- Tennessee Cleaning Company Fined $650,000 for Illegally Hiring Children, Some as Young as 13, to Clean Dangerous Slaughterhouses
- New York Is the World's Richest City, With Its Millionaires and Billionaires' Wealth Greater Than GDPs of Brazil, Canada, Italy
- AstraZeneca to Pull Out COVID-19 Vaccine Worldwide After Adverse Side Effect Admission
- Mini Gold Bars Are Causing a Frenzy in South Korea as Buyers Rush to Get Them in Convenience Stores, Vending Machines
- Joe Biden Administration Sanctions Colombian Maritime Companies Preying on Vulnerable Migrants Seeking to Enter US
- Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout
- Pfizer Settles 10,000 Zantac Heartburn Medication Lawsuits Over Cancer Risks
